Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

AZ initiates genome editing projects

Country: United Kingdom

AstraZeneca Plc is to work with four research institutes in the UK and the US to apply a genome editing technology known as CRISPR across its drug discovery platform. The collaborations are expected to yield new drug targets in preclinical models of disease.

Read more

Company with ‘gene pill’ receives funding

Country: Canada

Canada-based EnGene Inc, which has developed a gene-based technology to treat autoimmune diseases, has raised $11.5 million in a Series B investment round. The funds will be used to advance the lead product which is intended to treat ulcerative colitis.

Read more

New funds for UK gene therapy company

Country: United Kingdom

Read more

Novartis sees sales growth in 2015

Country: Switzerland

Read more

GSK poised to start trial of Ebola vaccine

Country: United Kingdom

Read more

Atlas project delivers clues on drug activity

Country: Sweden

Read more

New technique for culturing stem cells

Country: Netherlands

Read more

New UK oncology company launched

Country: United Kingdom

Read more

Bone Therapeutics in IPO on Euronext

Country: Belgium

Read more

FDA approves Novartis psoriasis drug

Country: United States

Read more

Pattern of malaria drug resistance described

Country: United Kingdom

Read more

AM-Pharma uses adaptive design for kidney injury studies

Country: Netherlands

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Biotech enters 2015 on an upswing, by Robin Davison

CommentaryRobinDavisonJan15.pdf

Highlights of the January 2015 MedNous issue

The January 2015 MedNous features:

Latest Mednous cover
  • Oncology Review
    2014 was a record
    year for approvals
    by Bruno Pagliara
  • Financial Strategy
    Looking for emerging science
    Interview with Forbion Capital
  • Business Strategy
    Biomarkers of the brain
    Interview with Cambridge Cognition
  • Commentary
    Was the Court misled in the Brüstle case?
    by Julian Hitchcock
  • Commentary
    Biotech enters 2015 on an upswing
    by Robin Davison

The latest MedNous journal. Subscribe to download.

Recent Appointments